Amphastar Pharmaceuticals, Inc (AMPH) insider trading

Every open-market stock purchase and sale by Amphastar Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Rong Zhou (Vice president) and 2 others sold $764K in the last 90 days.
  • Last company insider buy: David Maris (Board member), $20.3K, 6 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $1.7M (10 sales). Last close $27.72 on Oct 30, 2026.

Recent AMPH insider trades

DateInsiderTradeValue
Sep 21, 2026William J Peters (CFO)Sold$103K
Sep 16, 2026Rong Zhou (VP)Sold$239K
Sep 16, 2026Rong Zhou (VP)Bought (not open market)—
Sep 2, 2026Rong Zhou (VP)Sold$75.3K
Aug 11, 2026Richard K Prins (Insider)Sold$162K
Aug 7, 2026William J Peters (CFO)Sold$184K
Aug 7, 2026William J Peters (CFO)Bought (not open market)—
Jul 9, 2026Anthony T Pierce (Insider)Bought (not open market)—
Jul 9, 2026Anthony T Pierce (Insider)Bought (not open market)—
Jun 2, 2026Howard Lee (Insider)Sold (not open market)$14.2K
Jun 1, 2026Gayle Deflin (Insider)Bought (not open market)—
Jun 1, 2026Diane G. Gerst (Insider)Bought (not open market)—
Jun 1, 2026Richard K Prins (Insider)Bought (not open market)—
Jun 1, 2026Howard Lee (Insider)Bought (not open market)—
Jun 1, 2026David Russell Gaugh (Insider)Bought (not open market)—
Jun 1, 2026Gayle Deflin (Insider)Bought (not open market)—
Jun 1, 2026Howard Lee (Insider)Bought (not open market)—
Jun 1, 2026Diane G. Gerst (Insider)Bought (not open market)—
Jun 1, 2026Richard K Prins (Insider)Bought (not open market)—
Jun 1, 2026Michael A Zasloff (Insider)Bought (not open market)—
Jun 1, 2026Michael A Zasloff (Insider)Bought (not open market)—
Jun 1, 2026David Russell Gaugh (Insider)Bought (not open market)—
Mar 15, 2026Mary Z. Luo (COO)Sold (not open market)$178K
Mar 15, 2026Mary Z. Luo (COO)Sold (not open market)$52.9K
Mar 15, 2026William J Peters (CFO)Sold (not open market)$35.9K

Who's trading AMPH

Get free alerts when an insider at Amphastar Pharmaceuticals, Inc files a new trade →